Top News Today | Pfizer, J&J Alzheimer's drug fails one of 4 big trials | Tvshowbiz

Home
US
- Chicago
- Denver
- Los Angeles
- New York
- San Francisco
- Washington
Sport
- Baseball
- Basketball
- Boxing
- Football
- Golf
- Hockey
- MLB
- Motorsport
- NBA
- NFL
- NHL
- Soccer
- Tennis
Business
Technology
- Gadgetlab
- Green
- Internet
- Mobiles and Wireless
- PC Games
- Science
- Scitech
- Space
Lifestyle
- Art
- Beauty
- Books
- Culture
- Dining
- Fashion
- Health
- Style
- Travel
Entertainment
- Celebrity
- Games
- Gossip
- Movies
- Music
- Showbiz
- Tv
- Tvshowbiz
World
- Africa
- Asia-Pacific
- Canada
- China
- Europe
- India
- Japan
- Latin America
- Middle East
- Russia
- UK
Politics

Pfizer, J&J Alzheimer's drug fails one of 4 big trials

yahoo.com (9 months and 26 days ago)

Jul 24, 2012

(Reuters) - Pfizer Inc said on Monday its experimental Alzheimer's disease treatment failed to prove effective in one of four high-stakes late-stage trials of the medicine. The trial involved individuals who carry a variation of a gene called ApoE4 that makes them far more likely to develop Alzheimer's disease. Pfizer said it and its partner Johnson & Johnson will continue with three other late-stage trials of their medicine, called... full story

More news

Promising Alzheimer's drug Gammagard fails key study

Experimental drug failed to slow mental decline or preserve physical function in major trial of 390 patients with Alzheimer's

cbsnews.com (11 days ago)

QC Alzheimer's Treatment Forum on Clinical Trials

Press release submitted by Bawden & Lareau Public Relations Alzheimer's Association calls on Quad Citians to participate in clinical trials forum scheduled to battle growing health threat in both Iowa and Illinois

qconline.com (2 months and 21 days ago)

Bexarotene as Alzheimer's treatment begins Phase 1 clinical trials

The Alzheimer's Drug Discovery Foundation (ADDF) and BrightFocus Foundation today announced a funding collaboration that will support a Phase I human clinical trial to evaluate the cancer drug bexarotene as a treatment for Alzheimer's...

examiner.com (24 days ago)

Alzheimer's treatment one step closer to human trials at Case Western Reserve University

Last year, researchers at CWRU discovered that a cancer drug worked amazing well at treating Alzheimer's disease in mice. Now, they're one step closer to testing the drug in people.

cleveland.com (23 days ago)

Baxter drug fails to slow Alzheimer's in big study

Baxter International Inc. says that a blood product it was testing failed to slow mental decline or to preserve physical function in a major study of 390 patients with mild to moderate Alzheimer's disease.

indystar.com (11 days ago)

Alzhiemer drug Gammagard fails to slow Alzheimer’s disease in late stage trial

Baxter International Inc., a drug manufacturer, said Tuesday it will stop developing a drug for treating mild to moderate Alzheimer's disease after a late-stage study showed it failed to reduce the decline of cognitive functions and preserve...

examiner.com (11 days ago)

Pfizer Rises to the Occasion and Changes Big Pharma Forever

Filed under: Investing On this day in economic and financial history... Pfizer's Viagra (sildenafil citrate), the little blue pill with the big marketing campaign, was first cleared for sale by the FDA on March 27, 1998, becoming the first drug cleared to treat erectile dysfunction in the United States. Originally developed in 1989 at a Pfizer research facility in historic...

dailyfinance.com (1 month and 21 days ago)

Pfizer, J&J Alzheimer's drug fails one of 4 big trials

Advertisement

Most read

Most popular

Follow us

Search